Action NTRB NUTRIBAND INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Nutriband Inc.

Actions

NTRB

US67092M2089

Marché Fermé - OTC Markets
Autres places de cotation
 22:00:00 17/05/2024 		Varia. 5j. Varia. 1 janv.
4,47 USD -5,30 % Graphique intraday de Nutriband Inc. +33,04 % +92,67 %
16/05 Nutriband Inc. nomme Sergei Glinka à son conseil d'administration CI
01/05 Nutriband Inc. annonce ses résultats pour l'exercice clos le 31 janvier 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
Nutriband Inc. Appoints Sergei Glinka to Its Board of Directors
Tranche Update on Nutriband Inc.'s Equity Buyback Plan announced on December 30, 2021.
Tranche Update on Nutriband Inc.'s Equity Buyback Plan announced on December 30, 2021.
Tranche Update on Nutriband Inc.'s Equity Buyback Plan announced on December 30, 2021.
Nutriband Inc. Reports Earnings Results for the Full Year Ended January 31, 2024
Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa Fentanyl Transdermal Patch through FDA Submission
IBN Coverage Initiated for Nutriband Inc.
Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group
Nutriband Inc. Closes $8.4 Million Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
Nutriband Inc. announced that it expects to receive $8.4 million in funding
Nutriband Inc. Announces $8.4M Private Placement
Nutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New Balance
Nutriband Inc. Receives First Order from Fit for Life Group
Nutriband Inc. Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
Nutriband Inc. Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented At 2024 American Academy of Pain Medicine Annual Meeting
Nutriband Inc. Announces Data on the Incidence of Transdermal Patch Abuse and Accidental Pediatric Exposure Will Be Presented At the 2024 American Academy of Pain Medicine Annual Meeting
Nutriband Inc. to Present at the Microcap Conference Atlantic City January 30th through February 1st
Nutriband CEO Publishes Letter to Shareholders
Nutriband Signs Agreement With Kindeva Drug Delivery for Aversa Fentanyl
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action NTRB
  4. Actualités Nutriband Inc.
  5. Autres langues